Provexis (AIM:PXS) shares fell 11% as it warned that it will not meet the AIM deadline for publication of its annual accounts, as its audit for the year ended 31 March 2025 remains ongoing.
The company now expects to release the audited results by mid-October 2025.
As a result, Provexis shares will be temporarily suspended from trading on AIM from tomorrow, 1 October.
On an unaudited basis, the company said it expects to report a 61% rise in sales to £1.3 million, reflecting strong demand for its Fruitflow heart-health ingredient derived from tomatoes.
An underlying operating loss is anticipated to be £278,000, an improvement from a £0.47 million loss last time.
Cash at bank was £708,000.
It expects to report sales for the six months ended 30 September 2025 in excess of £350,000 and forecasts several hundred thousand pounds in further sales in the December quarter.
Provexis is also planning at least one more production run in the next 12 months to meet demand from existing and new customers.
The shares fell 0.071p to 0.59p.